A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
Status:
Recruiting
Trial end date:
2028-01-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether the combination of glofitamab and
lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma